wAIHA Treatment Landscape Update

The treatment landscape for wAIHA continues to evolve. The FDA has recently approved nipocalimab-aahu for warm autoimmune hemolytic anemia (wAIHA). FWGBD has updated its AIHA Resource Center to provide healthcare professionals with information about the approval, mechanism of action, supporting clinical evidence, safety considerations, and its potential place within the evolving treatment landscape.

---